These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 30134822)

  • 1. The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
    Mandel A; Larsson P; Sarwar M; Semenas J; Syed Khaja AS; Persson JL
    Mol Med; 2018 Jun; 24(1):34. PubMed ID: 30134822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
    Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
    Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.
    Lin HP; Ho HM; Chang CW; Yeh SD; Su YW; Tan TH; Lin WJ
    FASEB J; 2019 Dec; 33(12):14653-14667. PubMed ID: 31693867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
    Huo C; Kao YH; Chuu CP
    Cancer Lett; 2015 Dec; 369(1):103-11. PubMed ID: 26297988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.
    Larsson PF; Karlsson R; Sarwar M; Miftakhova R; Wang T; Syed Khaja AS; Semenas J; Chen S; Hedblom A; Ali A; Ekström-Holka K; Simoulis A; Kumar A; Wingren AG; Robinson B; Nyunt Wai S; Mongan NP; Heery DM; Öhlund D; Grundström T; Ødum N; Persson JL
    Mol Oncol; 2022 Jul; 16(13):2496-2517. PubMed ID: 34932854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells.
    Bonaccorsi L; Muratori M; Carloni V; Marchiani S; Formigli L; Forti G; Baldi E
    Steroids; 2004 Aug; 69(8-9):549-52. PubMed ID: 15288768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor and invasion in prostate cancer.
    Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
    Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2.
    Cai C; Portnoy DC; Wang H; Jiang X; Chen S; Balk SP
    Cancer Res; 2009 Jun; 69(12):5202-9. PubMed ID: 19491261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
    Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C
    Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: a model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model.
    Bonaccorsi L; Nosi D; Quercioli F; Formigli L; Zecchi S; Maggi M; Forti G; Baldi E
    Steroids; 2008 Oct; 73(9-10):1030-7. PubMed ID: 18358509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression.
    Xia D; Lai DV; Wu W; Webb ZD; Yang Q; Zhao L; Yu Z; Thorpe JE; Disch BC; Ihnat MA; Jayaraman M; Dhanasekaran DN; Stratton KL; Cookson MS; Fung KM; Lin HK
    J Steroid Biochem Mol Biol; 2018 Apr; 178():89-98. PubMed ID: 29155210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
    Bonaccorsi L; Carloni V; Muratori M; Formigli L; Zecchi S; Forti G; Baldi E
    Int J Cancer; 2004 Oct; 112(1):78-86. PubMed ID: 15305378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
    Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF
    Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
    Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
    Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.